PP_1170x120_10-25-21

Treatment and Care of Migraine) study

Lilly reports new data indicating rise in opioid use for migraine treatment

Lilly reports new data indicating rise in opioid use for migraine treatment

INDIANAPOLIS — Eli Lilly and Co. announced the upcoming presentation of data indicating rising rates of opioid use for the treatment of migraine based on results from the OVERCOME (Observational Survey of the Epidemiology, Treatment and Care of Migraine) study. These findings will be presented on Saturday, July 13, 2019, at the 61st Annual Scientific Meeting